Ganciclovir is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Pharmascience Inc.. The primary component is Ganciclovir Sodium.
Product ID | 51817-171_50d03656-3823-4955-a19c-5236736f8459 |
NDC | 51817-171 |
Product Type | Human Prescription Drug |
Proprietary Name | Ganciclovir |
Generic Name | Ganciclovir Sodium |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-04-24 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA207645 |
Labeler Name | Pharmascience Inc. |
Substance Name | GANCICLOVIR SODIUM |
Active Ingredient Strength | 500 mg/10mL |
Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-04-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA207645 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-04-24 |
Ingredient | Strength |
---|---|
GANCICLOVIR SODIUM | 500 mg/10mL |
SPL SET ID: | 3059c2da-d4a7-4aea-828c-20e671cb875c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9299 | Ganciclovir | Ganciclovir sodium |
14335-030 | Ganciclovir | ganciclovir sodium |
24201-500 | Ganciclovir | Ganciclovir |
25021-185 | ganciclovir | ganciclovir sodium |
42023-173 | Ganciclovir | Ganciclovir |
51754-2500 | GANCICLOVIR | GANCICLOVIR |
51817-171 | Ganciclovir | ganciclovir sodium |
63304-636 | GANCICLOVIR | GANCICLOVIR |
63304-637 | GANCICLOVIR | GANCICLOVIR |
63323-315 | Ganciclovir | GANCICLOVIR SODIUM |
70436-089 | Ganciclovir | ganciclovir sodium |
76233-072 | Ganciclovir | Ganciclovir Sodium |
0004-6940 | Cytovene | ganciclovir sodium |
61269-450 | Cytovene | ganciclovir sodium |
24208-535 | ZIRGAN | ganciclovir |